Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 162-167

  Arimura, Takuro ^a   Hayashi, Takeharu ^a   Matsumoto, Yuji ^a   Shibata, Hiroki ^a   Hiroi, Shitoshi ^a   Nakamura, Takeyuki ^a   Inagaki, Natsuko ^a   Hinohara, Kunihiko ^a   Takahashi, Megumi ^a   Manatsu, Satoh Itoh ^a   Sasaoka, Taishi ^a,b   Izumi, Toru ^b   Bonne, Gisèle ^c,d,e   Schwartz, Ketty ^c,d   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dilated cardiomyopathy; Four and half LIM protein 2; Mutation; Titin connectin

Indexed keywords

CONNECTIN; FOUR AND HALF LIM PROTEIN 2; LIM PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; SARCOMERE;

AMINO ACID SEQUENCE; CARDIOMYOPATHY, DILATED; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 34147100523     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.128     Document Type: Article

References (27)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., and Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326 (1992) 77-82
3. Kimura A., Ito-Satoh M., Hayashi T., Takahashi M., and Arimura T. Molecular etiology of idiopathic cardiomyopathy in Asian populations. J. Cardiol. 37 Suppl. 1 (2001) 139-146
4. Morita H., Seidman J., and Seidman C.E. Genetic causes of human heart failure. J. Clin. Invest. 115 (2005) 518-526
5. Tskhovrebova L., and Trinick J. Titin: properties and family relationships. Nat. Rev. Mol. Cell Biol. 4 (2003) 679-689
6. Granzier H.L., and Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ. Res. 94 (2004) 284-295
7. Flashman E., Redwood C., Moolman-Smook J., and Watkins H. Cardiac myosin binding protein C: its role in physiology and disease. Circ. Res. 94 (2004) 1279-1289
8. Daehmlow S., Erdmann J., Knueppel T., Gille C., Froemmel C., Hummel M., Hetzer R., and Regitz-Zagrosek V. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298 (2002) 116-120
9. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.S., and Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 (1998) 750-752
10. Mohapatra B., Jimenez S., Lin J.H., Bowles K.R., Coveler K.J., Marx J.G., Chrisco M.A., Murphy R.T., Lurie P.R., Schwartz R.J., Elliott P.M., Vatta M., McKenna W., Towbin J.A., and Bowles N.E. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 80 (2003) 207-215
11. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E., Knoll R., Hoshijima M., Chien K.R., and Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
12. Inagaki N., Hayashi T., Arimura T., Koga Y., Takahashi M., Shibata H., Teraoka K., Chikamori T., Yamashina A., and Kimura A. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 342 (2006) 379-386
13. Itoh-Satoh M., Hayashi T., Nishi H., Koga Y., Arimura T., Koyanagi T., Takahashi M., Hohda S., Ueda K., Nouchi T., Hiroe M., Marumo F., Imaizumi T., Yasunami M., and Kimura A. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 291 (2002) 385-393
14. Matsumoto Y., Hayashi T., Inagaki N., Takahashi M., Hiroi S., Nakamura T., Arimura T., Nakamura K., Ashizawa N., Yasunami M., Ohe T., Yano K., and Kimura A. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J. Muscle Res. Cell Motil. 26 (2005) 367-374
15. Genini M., Schwalbe P., Scholl F.A., Remppis A., Mattei M.G., and Schafer B.W. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol. 16 (1997) 433-442
16. Chan K.K., Tsui S.K., Lee S.M., Luk S.C., Liew C.C., Fung K.P., Waye M.M., and Lee C.Y. Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 210 (1998) 345-350
17. Johannessen M., Moller S., Hansen T., Moens U., and Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol. Life Sci. 63 (2006) 268-284
18. Purcell N.H., Darwis D., Bueno O.F., Muller J.M., Schule R., and Molkentin J.D. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell Biol. 24 (2004) 1081-1095
19. Kong Y., Shelton J.M., Rothermel B., Li X., Richardson J.A., Bassel-Duby R., and Williams R.S. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 103 (2001) 2731-2738
20. Lange S., Auerbach D., McLoughlin P., Perriard E., Schafer B.W., Perriard J.C., and Ehler E. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 115 (2002) 4925-4936
21. Arimura T., Hayashi T., Terada H., Lee S.Y., Zhou Q., Takahashi M., Ueda K., Nouchi T., Hohda S., Shibutani M., Hirose M., Chen J., Park J.E., Yasunami M., Hayashi H., and Kimura A. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J. Biol. Chem. 279 (2004) 6746-6752
22. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., Hiroi S., Sasaoka T., Ohbuchi N., Nakamura T., Koyanagi T., Hwang T.H., Choo J.A., Chung K.S., Hasegawa A., Nagai R., Okazaki O., Nakamura H., Matsuzaki M., Sakamoto T., Toshima H., Koga Y., Imaizumi T., and Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16 (1997) 379-382
23. Sanchez-Garcia I., and Rabbitts T.H. The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet. 10 (1994) 315-320
24. Perez-Alvarado G.C., Miles C., Michelsen J.W., Louis H.A., Winge D.R., Beckerle M.C., and Summers M.F. Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP. Nat. Struct. Biol. 1 (1994) 388-398
25. Arber S., Hunter J.J., Ross Jr. J., Hongo M., Sansig G., Borg J., Perriard J.C., Chien K.R., and Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88 (1997) 393-403
26. Pashmforoush M., Pomies P., Peterson K.L., Kubalak S., Ross Jr. J., Hefti A., Aebi U., Beckerle M.C., and Chien K.R. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med. 7 (2001) 591-597
27. Linke W.A., Rudy D.E., Centner T., Gautel M., Witt C., Labeit S., and Gregorio C.C. I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J. Cell Biol. 146 (1999) 631-644